Krystal Biotech, Inc. KRYS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s PP&E (net)?
- Krystal Biotech, Inc. (KRYS) reported PP&E (net) of $153.58M in Q1 2026.
- How has Krystal Biotech, Inc.'s PP&E (net) changed year-over-year?
- Krystal Biotech, Inc.'s PP&E (net) increased by 1.7% year-over-year, from $151.07M to $153.58M.
- What is the long-term trend for Krystal Biotech, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s PP&E (net) has grown at a 37.3% compound annual growth rate (CAGR), from $30.88M to $150.78M.
- What does PP&E (net) mean?
- The net value of the company's physical assets like buildings and equipment.
- How do you interpret PP&E (net)?
- An increase indicates capital investment in infrastructure, while a decrease reflects depreciation or the disposal of assets.
- How does PP&E (net) compare across companies?
- Varies significantly based on whether a company owns or outsources its manufacturing and lab facilities.